Novartis gets positive result from breast-cancer drug trial

Novartis AG said Monday that a trial evaluating breast-cancer drug Kisqali met its primary endpoint during an interim analysis. The drug is shown to significantly reduce the risk of disease recurrence when used together with an endocrine therapy in patients with certain types of early breast…#novartisag #natalee #novartisnovn #novn
Source: Reuters: Health - Category: Consumer Health News Source Type: news